Gaviscon

Product NDC: 0135-0096
11-digit product format: 001350096
Labeler code: 0135
Product ID: 0135-0096_75b2ec9d-9891-4da9-8aa0-868851ba6ff0
Type: HUMAN OTC DRUG
Nonproprietary name: aluminum hydroxide and magnesium trisilicate
Dosage form: TABLET, CHEWABLE
Route: ORAL
Labeler: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Application: NDA018685
Marketing category: NDA
Marketing start: 2011-06-13
Marketing end: 0000-00-00
Substance: ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE
Active strength: 80 mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0135-0096		D	Discontinued by firm		2026-10-05
excluded package	package	0135-0096	0135-0096-26	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 20 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0135-0096-26	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0135-0096-26	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0135-0096-26	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0135-0096-26	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0135-0096-26	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0135-0096-26	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0135-0096-26	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0135-0096-26	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0135-0096-26	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	0135-0096-26	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N018685-001	GAVISCON	ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL		RLD	1983-12-09
N018685-002	GAVISCON	ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL		RLD	1983-12-09

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N018685-001	GAVISCON	80MG;20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N018685-002	GAVISCON	160MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018685-001	GAVISCON	80MG;20MG	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N018685-002	GAVISCON	160MG;40MG	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N018685-001	GAVISCON	80MG;20MG	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N018685-002	GAVISCON	160MG;40MG	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N018685-001	GAVISCON	80MG;20MG	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N018685-002	GAVISCON	160MG;40MG	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N018685-001	GAVISCON	80MG;20MG	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N018685-002	GAVISCON	160MG;40MG	TABLET, CHEWABLE / ORAL	RLD	1983-12-09	`74a2ff9319b5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
Effective	Related label
2025-02-01	Drug Facts
2022-07-29	Drug Facts
2020-11-18	Drug Facts
2020-01-31	Drug Facts

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0135-0096-26	EA - Each	0135-0096	b8fb8b49-be2f-4bfe-b1a2-db76d55f10ed	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ALUMINUM HYDROXIDE	ACTIVE INGREDIENT	5QB0T2IUN0	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
MAGNESIUM CARBONATE	ACTIVE INGREDIENT	0E53J927NA	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
MAGNESIUM TRISILICATE	ACTIVE INGREDIENT	C2E1CI501T	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
ALUMINUM HYDROXIDE	ACTIVE MOIETY	5QB0T2IUN0	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
CARBONATE ION	ACTIVE MOIETY	7UJQ5OPE7D	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
MAGNESIUM CATION	ACTIVE MOIETY	T6V3LHY838	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
ACESULFAME POTASSIUM	INACTIVE INGREDIENT	23OV73Q5G9	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
ALGINIC ACID	INACTIVE INGREDIENT	8C3Z4148WZ	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
CALCIUM STEARATE	INACTIVE INGREDIENT	776XM7047L	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
CORN SYRUP	INACTIVE INGREDIENT	9G5L16BK6N	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
SODIUM BICARBONATE	INACTIVE INGREDIENT	8MDF5V39QO	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
SORBITOL	INACTIVE INGREDIENT	506T60A25R	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6
SUCROSE	INACTIVE INGREDIENT	C151H8M554	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]	6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0135-0096	GAVISCON EXTRA STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE) TABLET, CHEWABLE GAVISCON REGULAR STRENGTH (ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE) TABLET, CHEWABLE [HALEON US HOLDINGS LLC]	16	Legacy NDC	20250516_7f367927-c366-465c-a059-e2cfb337d562.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
5QB0T2IUN0	ALUMINUM HYDROXIDE	21645-51-2	ALUMINUM HYDROXIDE
C2E1CI501T	MAGNESIUM TRISILICATE	39365-87-2	MAGNESIUM TRISILICATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0135-0096-26	00135009626	100 TABLET, CHEWABLE in 1 BOTTLE (0135-0096-26)	2011-06-13	0000-00-00	No	No	Current